Sensory neurons of the PNS derive from 2 transient embryonic structures: the neural crest and the ectodermal placodes (LeDouarin, 1982) . From the crest are formed the dorsal root sensory ganglia (DRG) along the spinal column and the sympathetic chain, and at a mesencephalic level, along the parasympathetic ganglia of the head. The ectodermal placodes contribute neurons to sensory ganglia located along the cranial nerves. The neurons comprising the various peripheral ganglia respond differentially to the neuronal growth factors thus far characterized: NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) ciliary neurotrophic factor (CNTF), and the fibroblast growth factors (FGFs; see Barde et al., 1982; Barbin et al., 1984; Davies, 1987; Unsicker et al., 1987; Maisonpierre et al., 1990) . NGF, BDNF, and NT-3 are members of a gene family and share greater than 50% homology (Hohn et al., 1990; Maisonpierre et al., 1990) .
NGF and BDNF are highly homologous in amino acid sequence, though their spectrum of target neurons do not overlap. NGF, but not BDNF, supports the growth of sympathetic neurons in culture, while BDNF, but not NGF, supports the growth of placode-derived nodose sensory neurons in culture (Lindsay et al.,' 1985; Davies et al., 1986) . High-affinity receptors for BDNF have been demonstrated on nodose neurons but are not expressed by sympathetic neurons (Rodrigeuz-Tebar and . Both factors act on crest-derived sensory DRG neurons, but apparently on nonoverlapping populations, as well, as their effects in culture are additive. Crest-derived parasympathetic neurons of the ciliary ganglion respond to CNTF (Helfand et al., 1976; Barbin et al., 1984; Manthorpe et al., 1986) or to fibroblast growth factors (Unsicker et al., 1987) in culture, but not to BDNF or NGF. Like the FGFs, the polypeptide precursor of CNTF lacks a signal sequence and may not be actively secreted (Lin et al., 1989; Stockli et al., 1989) . Unlike the FGFs, the biological activity of CNTF is not potentiated by heparin.
NGF has the best established role in viva (Levi-Montalcini and Booker, 1960a,b) . In most parts of the nervous system, more neurons are generated during embryonic development than will survive as development reaches completion. Sympathetic neurons and some sensory neurons within the DRG are exquisitely sensitive to NGF in vivo. Injection of exogenous NGF supports the survival of enhanced numbers of sympathetic and DRG sensory neurons (Hendry and Campbell, 1976; Hamburger et al., 198 l) , while blockade of NGF action by injection of antibodies to NGF decreases neuronal survival (Gorin and Johnson, 1979; Goedert et al., 1984) . NGF has a similar action in vitro: sympathetic and DRG sensory neurons can be maintained in culture by addition of NGF to the culture medium, while the cultured neurons deprived of trophic support rapidly die due to an active death program (Martin et al., 1988) .
Like NGF, a biological role for BDNF in vivo is becoming apparent. The neurons that respond to BDNF in culture, nodose neurons and a subpopulation of DRG neurons, can also be rescued by BDNF in vivo. During naturally occurring cell death, administration of exogenous BDNF can rescue DRG and nodose sensory neurons that otherwise would have died (Hofer and Barde, 1988) .
Peripheral sensory neurons are proposed to receive neurotrophic support both from peripheral target tissues and from the CNS. NGF is present in the peripheral target tissues of sensory DRG neurons (Korsching and Thoenen, 1983) and interruption of its retrograde transport results in sensory neuron death (Johnson et al., 1986) . BDNF is believed to be the centrally derived neurotrophic factor. Central rhizotomy of the DRG in newborn rats or avian embrvos (Kalcheim et al.. 1987 ) also Preparation offactors. BDNF was partially purified from adult porcine < \ results in the death of a proportion of the neurons (Yip and brain according to the method of Lindsay et al. (1985) by acidprecip- Johnson, 1984) . BDNF has been shown to rescue avian DRG itation and chromatography over CM-cellulose (Whatman) and hyneurons in viva that normally died after separation from the droxylapatite (BioRad) to a specific activity of 2 rg protein/ml for maxspinal cord, suggesting that it is a CNS-derived factor that is imal neurite extension by cultured DRG neurons. Partially purified CNTF was prepared according to the method of Barbin et al. (1984) important in early development. Unlike NGF, BDNF mRNA from E8-El4 embryonic chick eyes by chromatography over DEAEis highly expressed in the adult CNS, but not in other tissues cellulose (Whatman). Human platelet-derived growth factor (hPDGF), (Leibrock et al., 1989) . acidic fibroblast growth factor (aFGF), and basic fibroblast growth factor
In the present study, we report that human platelets contain (bFGF) were purchased from R&D Systems, and NGF was purchased from Sigma Chemical Company. BDNF mRNA, as well as the mature factor, based on its bioTo prepare human platelets, blood was collected from healthy adult logical and biochemical characterization. BDNF from human platelets supports the growth in culture of chick sensory nodose and DRG neurons and has the expected molecular weight on SDS-PAGE.
Oligonucleotiode primers based on the nucleotide sequence ofa pig BDNF cDNA (Leibrock et al., 1989 ) amplified a partial BNDF cDNA from human platelets using the polymerase chain, reaction.
Remarkably, the deduced partial amino acid sequence of human BDNF (99 residues of 120) has complete sequence identity to pig BDNF.
Materials and Methods
Dissociated neuron-enriched culture. Spinal lumbar DRG, nodose and sympathetic ganglia, and parasympathetic ciliary ganglia were dissected from White Leghorn chicken embryos that were incubated for 7 (E7) to 13 d (El 3). Ganglia were collected into calcium and magnesium-free Hank's balanced salt solution (CMF-HBSS).
The ganglia were cleaned of adherent tissue. then digested with 0.03-0.6% (w/v) trvnsin (GIBCO). depending upon the age of the embryo, in CMF-H&S-for I5 min at 37°C. Typically, 0.03% trypsin was used for digestion of E8 DRG and 0.07% for El 3 nodose ganglia. Trypsin digestion was terminated by the addition of l/l0 vol horse serum (HS). Ganglia were collected by centrifugation, rinsed once with F14 medium containing 10% HS, then resuspended in the same medium. The tissue was dispersed by gentle trituration, then brought up in 4 ml medium. To enrich for neurons, the cells were layered on top of a cold, 4-ml metrizamide (Sigma) cushion, which was made up in PBS to a density of 1.063 gm/ml at room temperature. The cells were then centrifuged at 560 x g for 15 min at 4°C. Neurons were collected in the pellet, rinsed once with medium containing 10% HS, then resuspended in the culture medium. Without metrizamide centrifugation, non-neuronal cell contamination was greater than 50% of the cells plated. After metrizamide centrifugation, nonneuronal cell number declined to 5-10% of the cells placed in culture. Cells were plated on poly-m-omithine-(0.5 mg/ml in 150 mM sodium borate buffer) and laminin-(Collaborative Research, 50 pg'rnl in PBS), coated 12-well tissue culture plates (Costar) at a density of 500-1000 cells/cm*. Sympathetic neurons were plated without metrizamide separation. The culture medium consisted of FlO medium (Sigma) with 10% heat-inactivated HS (GIBCO) and F14 supplements. To accurately count the number of cells plated, squares enclosing 0.4 cm x 0.75 cm of the central area in each culture well were scored on the bottom of the plate. Cultures were incubated at 37°C in an atmosphere of 5% CO, in humidified air. The numbers of cells in each well were counted after 1 hr incubation to determine the number seeded per well. After 2 or 4 d growth in vitro, the numbers of neurons with or without processes greater than 5 cell diameters then were counted at a magnification of 100x.
donors in heparinized tubes and diluted into an equal volume of CMF-HBSS containing l/S vol 200 mM Na,EDTA, 145 mM NaCl, and 25 mM Tris buffer (pH, 6.6) (TEN buffer). Platelets were handled at room temperature. Nucleated cells were oelleted bv low-soeed centrifueation at 2bO x g for 15 min, the platelet-rich supernatan; was collected and the platelets pelleted by centrifugation at 1300 x g for 10 min, then the platelet pellet was washed twice with CMF-HBSVTEN buffer. Platelets from the rabbit, pig, and calf were prepared in the same manner. Contamination of the platelet fraction by nucleated cells ranged from 6 to 8% as assessed with a particle counter (Coulter Model ZF).
For extraction, 100 mg wet-weight platelets (from approximately 100 ml blood) were homogenized with a Teflon-glass homogenizer in 2 ml distilled water and centrifuged at 45,000 x 2 for 20 mm. The extract contained 14 mg protein and was used for the culture assays described in the following text.
Culture media used were FlO with F14 supplements (4.9 mM glucose, 0.2 mM L-alanine, 10 PM putrescine, 1.25 mM pyruvate, 100 FM inositol, 0.1 mM choline-Cl, 1.22 mM CaCl,, 14.3 mM NaHCO,). Nl medium was FlO/F14 medium supplemented with BSA/linoleic acid complex (Collaborative Research) at 100 &ml, human transfenin (Sigma) at 100 pg'ml, 0.19 FM progesterone, 0.1 mM putrescine, and 0.3 PM selenous acid (Na salt). Penicillin was included at 100 U/ml, and streptomycin at 100 &ml.
Platelet extracts or partially purified factors were tested for effects on E8, E9, E 10, and E 12 DRG neurons, E8, E9, and E 13 nodose neurons, E9 ciliary neurons, and E 12 sympathetic neurons. As positive controls, DRG and sympathetic neurons were grown with NGF, and sensory and ciliary neurons were grown with partially purified BDNF and CNTF, respectively.
Partial purt$cation of BDNF from platelets by cation-exchange chromatography. Concentrated sodium phosphate buffer (pH, 6.0) was added to a volume of platelet extract containing 100 mg protein to bring the solution to 10 mM sodium phosphate. This was loaded onto a CMsepharose 4B column (Pharmacia; dimensions, 1.6 x 10 cm) previously equilibrated to 10 mM sodium phosphate buffer (pH, 6.0). The column was washed with 10 mM sodium phosphate until unbound protein was eluted, then with 10 column volumes 10 mM sodium phosphate buffer containine. 0.3 M NaCl. BDNF was eluted with Dhosohate buffer containing 0.3 M NaCl, and active fractions were iden&ed by bioassay with DRG neurons, then pooled and concentrated with an Amicon YM-10 membrane.
Factors were used for cultures at concentrations that elicited maximal neurite outgrowth and survival unless otherwise noted. Typically, partiallv purified nia brain BDNF was used at 2 &ml. the 0.5 M NaCl CMIsepharose eliate containing partially purified lhum'an platelet BDNF was used at 300 rig/ml, and purified NGF was used at 10 @ml. Protein concentration was measured with the Bio-Rad protein assay.
SDS-Page. SDS-polyacrylamide gels contained 14% acrylamide and 0.134% bis-acrylamide.
Usually, 150-200 fig protein from platelet extract was loaded per gel lane in 0.24 M T&-Cl sample buffer (pH, 6.8) without SDS or reducing agent. Gels were electrophoresed overnight at 8 mA per 1.5-mm-thick gel. Rhodamine-conjugated cytochrome C was used as a colored indicator of molecular weight. Gels were sliced at 2-mm intervals across 6 lanes of loaded protein. The gel slices were macerated, then extracted for up to 4 d in 300 ~1 3% BSA in CMF-HBSS at 4°C. Two hundred ~1 extract was separated from the gel fragments by centrifugation, and 100 ~1 of each extract was bioassayed on cultures of DRG or nodose neurons.
Detection ofBDNF mRNA in human platelets by reverse transcriptasepolymerase chain reaction (RT-PCR).
Total RNA of human platelets was isolated as described (Newman et al., 1988) . In 1 experiment, RNA was isolated from platelets obtained in 240 ml fresh blood, and in a second experiment, 1 Unit of platelets obtained from a local blood bank was used. Platelets were pelleted by centrifugation, then solubilized in 8 ml buffer containing 4 M guanidium isothiocyanate, 5 mM sodium citrate, 0.1 M 2-mercaptoethanol, 0.5% Sarkosyl, 0.1% Antifoam A and RNasin (Promega) at 40 U/ml. Then the platelets were layered onto a 1.5-ml cushion of 5.7 M cesium chloride and centrifuged in an SW 4 1 rotor (Beckman) at 25,000 rpm for 16 hr. The RNA pellet was resuspended in 10 mM Tris (pH, 8) and 1 mM Na,EDTA (TE buffer), then precipitated with ethanol. As a positive control, polyA+ RNA also was isolated from a human astrocytoma cell line, U-87 MG, and from mouse brain according to the manufacturer's instruction (mRNA isolation kit, Invitrogen). Oligonucleotides were synthesized with P-cyanoethyl phosphoramidite chemistry on an Applied Biosystems 38 1A DNA synthesizer using trityl-off synthesis. The oligonucleotide was cleaved and deprotected with ammonium hydroxide, then purified over Sephadex , and 1.5 U Taq polymerase. Amplification was performed on a programmable heater (Techne). The reaction cycle consisted of denaturation at 94°C for 0.3 min, annealing at 53°C for 0.5 min, and elongation at 68°C for 0.5 min. After 35 cycles, aliquots of the PCR reactions were electrophoresed on 1% agarose gels. As a control for contamination of the platelet RNA by human genomic DNA, PCR amplifications were performed that included every reagent except for the M-MLV RT.
To clone the PCR product into an M 13 vector for DNA sequencing, amplified DNA bands of the expected size were recovered from the agarose gel, then phosphorylated with T4 polynucleotide kinase. The DNA fragment was then ligated into a Smal cut and dephosphorylated M13mp8 vector and transformed into JM109 cells. The sequence of the DNA insert was determined by dideoxynucleotide sequencing (Sequenase, U.S. Biochemical).
Results
Detection of BDNF biological activity in human platelets BDNF biological activity was detected in human platelets in initial experiments designed to examine the release of neurotrophic factors by human peripheral blood mononuclear cells (MNCs). MNCs were isolated by centrifugation on Ficoll-Hypaque, then stimulated by 18 hr culture with phytohemagglutinin, pokeweed mitogen, or lipopolysaccharide (LPS) according to standard protocols (Gurney et al., 1986) . The supematant medium was collected from the cultures, then tested for neurotrophic support of E 10 DRG neurons. LPS-stimulated MNCculture supernatants promoted the growth of cultured DRG neurons, while supematants from the lectin-stimulated MNC cultures were without effect. The source of neurotrophic activity was eventually traced to the platelet fraction and could be released by extraction of human platelets with distilled water. Among the species tested, extracts of human platelets contained greater neurotrophic activity than those of the rabbit or pig. No activity was detected in extracts of bovine platelets.
Characterization of the types of peripheral neurons responsive to the platelet extract revealed a spectrum of biological activity similar to that of BDNF (Lindsay et al., 1985; Davies et al., 1986; Davies, 1987) . Preliminary characterization of the neurotrophic activity in human platelets revealed that nodose and DRG sensory neurons were responsive to the platelet extract, while no response was shown by sympathetic or ciliary neurons (as in Figs. 1, 2) . Autonomic neurons of sympathetic ganglia and of ciliary ganglia were responsive to NGF and to a factor in embryonic eye extract, respectively, but were not responsive to the platelet extract (Fig. 2) .
The neurotrophic activity of the platelet extract was completely lost after boiling for 2 min or after treatment with trypsin. For the trypsin inactivation experiment, 50 ~1 platelet extract (0.4 mg protein/ml) was digested with 0.05% (w/v) trypsin for 2 hr at 37°C. The digest was then diluted 40-fold into medium containing 10% HS to give a final platelet extract concentration of 10 &ml in 10% HS and a negligible trypsin concentration of 0.0012%. The neurotrophic activity in the platelet extract was completely eliminated when bioassayed with nodose neurons, which suggested that the neurotrophic activity was due to 1 or more proteins in the extract.
We also tested whether or not human PDGF and basic or acidic FGF could account for the neurotrophic activity observed in platelet extracts. Neither DRG nor nodose neurons could be maintained in culture by hPDGF at 1 or 10 r&ml or by aFGF tested at 10, 25, and 50 rig/ml. At the same concentrations, bFGF showed weak neuritogenic and survival activity on E9 nodose neurons. The potency of bFGF was, however, different from that of the factor in human platelets, as less than 5% of nodose neurons plated could be maintained in culture with bFGF compared to 20-30% with addition of the platelet extract.
Partial purijication of BDNF from platelets In both DRG and nodose sensory neuron cultures, dose-response curves were similar with i/z maximum neurite outgrowth obtained with the platelet extract added at a concentration of approximately l-2 pg protein per ml in serum-free Nl medium. Maximum neurite outgrowth was obtained with the extract at 4-6 PLg protein per ml in N 1 medium and 12-l 6 pg protein per ml in Fl O/ 14 medium supplemented with 10% HS. Preliminary chromatography of the platelet extract over CM-cellulose at pH 6.0 or DEAE-cellulose at pH 8.0 (both in 10 mM sodium phosphate buffer) indicated that the neurotrophic activity was absorbed onto the cation exchanger as expected for BDNF (Barde et al., 1982) . On chromatography of 100 mg platelet-extract protein over CM-sepharose, a small amount of neurotrophic activity was recovered in the column flow-through, and no neurotrophic activity was eluted with a low-salt wash (0.3 M NaCl in 10 mM sodium phosphate buffer at pH 6.0), while the majority of loaded activity was recovered in the high-salt eluate (0.5 M NaCl in sodium phosphate buffer). One-half maximum neurotrophic activity for the 0.5 M NaCl eluate was achieved at a protein concentration of 30 rig/ml in Nl medium, which is an approximately 50-fold increase in specific activity over the platelet extract. Recovery ofneurotrophic activity was estimated to be 30%. For routine cultures, 300 n&ml of partially purified platelet BDNF was used for each assay, and this showed the full activity obtained with the platelet extract.
Comparison ofplatelet BDNF with pig brain BDNF
The survival of E9 neurons from the DRG or nodose ganglia without the addition of neurotrophic factors to the culture medium was very low by 4 d in culture (Fig. 3a,b) . NGF (on DRG neurons only), pig brain BDNF, and human platelet BDNF demonstrated an increasing effect on survival of process-bearing neurons with longer culture periods. By 4 d, neuritogenic and survival activity were closely related as DRG or nodose sensory neurons without processes preferentially died. Platelet BDNF had % the neuritogenic activity of NGF and equal potency with BDNF on E9 DRG neurons after 4 d in culture (Fig. 3a) . On nodose neurons, the neurite outgrowth and survival were slightly higher with pig brain BDNF than with human platelet BDNF (Fig. 36) . These results suggested that long-term survival of both v [11 Figure 2 . BDNF from human platelets supports placode and neural crest-derived sensory neurons, but not autonomic neurons in dissociated cell culture. Neurons from E9 DRG, E9 nodose ganglia (NG), E 12 sympathetic ganglia (SYM), and E9 ciliary ganglia (CZL) were cultured with NGF (10 r&ml), partially purified pig brain BDNF (2 &ml), chick embryonic eye extract (100 @g/ml), partially purified platelet BDNF (platelet-CM, 300 &ml), or human platelet extract (20 &ml). Processbearing DRG and nodose neurons were counted after 4 d in culture. Process-bearing autonomic neurons from El2 sympathetic ganglia and E9 ciliary ganglia were counted after 2 d in culture (n = 4; values are mean f SD). No neutrophic activity was detected in the platelet extract in bioassays with autonomic neurons.
DRG and nodose neurons in response to added BDNF from pig brain or human platelets was similar and was associated with neurite outgrowth (Fig. 3a,b) .
It has been previously shown that the survival effects of NGF and pig brain BDNF are strictly additive in cultures of late embryonic El2 DRG neurons (Lindsay et al., 1985) . A similar result was obtained when human platelet BDNF was tested alone or in combination with NGF. The 2 factors had an additive effect when tested on El0 DRG neurons (Fig. 4) . No additivity was observed with pig brain and human platelet BDNF tested in combination on nodose sensory neurons, which confirmed their biological equivalence. Apparent molecular weight of platelet BDNF determined by SDS-PAGE To establish the apparent molecular weight of platelet BDNF, the platelet extract was subject to SDS-PAGE (14% acrylamide, 0.135% bis-acrylamide gels) together with the molecular weight markers carbonic anhydrase (29,000 Da), P-lactoglobulin (18,400 Da), lysozyme (14,300 Da), and cytochrome C (12,500 Da). The cytochrome C was labeled with rhodamine B isothiocyanate to provide a colored marker with which to identify gel slices of interest. Neurotrophic activity for cultured DRG and nodose neurons consistently comigrated with rhodamine-conjugated cytochrome C at an apparent IV, of 13,000 Da (Fig. 5) , which is similar to the apparent molecular weight on SDS-PAGE reported for pig brain BDNF (Barde et al., 1982) and deduced from the pig brain BDNF cDNA (Leibrock et al., 1989) . Neurotrophic activity was eluted from the sliced gel as a single peak with an identical mobility when bioassayed on either cultured DRG or nodose neurons. No activity of a possible dimer of 20,000-30,000
Da was observed in the SDS-PAGE experiments. Platelet BDNF showed the same potency (i.e., neuritogenic activity or numbers of neurons surviving at the neurons that responded to platelet BDNF was r/z the number that responded to NGF. For all treatments, counts of process-bearing neurons were similar after 2 and 4 din culture, while cell death was preferentially associated with neurons that failed to extend processes.
concentration of maximum effect), whether partially purified by SDS-PAGE or by CM-sepharose chromatography, as compared to the platelet extract. PCR has allowed the molecular cloning of the cDNA encoding platelet glycoprotein IIIa (Newman et al., 1988) . In designing primers for amplifying a BDNF cDNA, we chose regions of BDNF sequence that we thought might be conserved between species based on its high homology to NGF. Like NGF, BDNF is synthesized initially as part of a larger precursor of 252 amino acids from an mRNA of 1184 nucleotides. Proteolytic processing occurs at a pair of dibasic residues (after Arg'32) to liberate the amino terminus of mature BDNF. Mature BDNF contains 119 amino acids. The highest homology between pig and human BDNF was expected to be in the region of the cDNA encoding the mature factor rather than in the upstream sequences encoding the processed polypeptide precursor. The sequences of BDNF and NGF have complete identity of cysteine residues. High homology is observed within the sequences around the first cysteine residue (12 of 14 matches) and around the last cysteine residue (12 of 14 matches). Sequences upstream of the first cysteine codon also have low degeneracy of codon usage. These 2 regions were chosen for primary synthesis. One of the upstream, sense PCR primers (primer 2) and both of the downstream, antisense PCR primers (primers 3, 4) successfully amplified BDNF cDNA fragments (Table 1, Fig. 6 ).
Detection of BDNF mRNA in human platelets was performed by cDNA synthesis with M-MLV RT followed by DNA amplification with the Taq PCR. The expected sizes of the BDNF cDNA fragments amplified by primers 2/3 and 2/4 are 345 and 3 15 base pairs (bp), respectively. As a positive control for RT-PCR, we used polyA+ mRNA from the mouse brain. The high level of expression of BDNF mRNA in the mouse brain detected by Northern hybridization (Leibrock et al., 1989) suggested that the hybridization signal might be due in part to BDNF mRNA expression in astrocytes. As an additional positive control for RT-PCR, therefore, we included polyA+ mRNA isolated from a human astrocytoma cell line, U-87 MG. RT-PCR amplified single DNA fragments of the expected sizes from both mouse brain and U-87 MG polyA+ mRNA ( Fig. 7 ; only U-87 MG is shown). A BDNF cDNA fragment was amplified from total platelet RNA after priming the RT reaction with either random oligonucleotides or oligo dT; however, cleamer PCR amplification was obtained with oligo dT-primed cDNA synthesis (Figs. 7, 8) . The result indicates that the megakaryocyte expresses BDNF mRNA and supports our identification of the neurotrophic factor in human platelets as BDNF.
Due to the high sensitivity of RT-PCR, one concern was the possible contamination of the platelet RNA with human genomic DNA. As a control, therefore, PCR amplifications of platelet RNA were performed without cDNA synthesis by M-MLV RT. No amplification of BDNF DNA was detected (Fig. 8, lane 5 ). neurons/cm* neurons/cm* Figure 5 . Fractionation of human platelet extract by SDS-PAGE on 14% acrylamide, 0.134% bis-a&amide gels. Growth-promoting activity was assayed with E7 nodose neurons and E8 DRG neurons cultured in serum-free Nl medium lacking insulin. On the Coomassie blue-stained gel were loaded carbonic anhydrase (29,000 Da), @-lactoglobulin (18,400 Da), and lysozyme (14,300 Da; MW, lane 1); rhodamine-conjugated cytochrome C (12,500-l 3,500 Da; cytC, lane 2), and human platelet extract (PEx, lanes 3-5) at 150 pg protein per lane. The gel was sliced, and the indicated slices were extracted and tested for growth-promoting activity. Gel slices were numbered with respect to the position of the rhodamine-labeled cytochrome C (gel slice 5). Data from 4 separate experiments are shown. Neurotrophic activity co-electrophoresed with rhodamine-labeled cytochrome C as a single peak of identical mobility when bioassayed with either nodose or DRG neurons. Due to our concern that the BDNF PCR primers might also amplify a NGF cDNA because of the high homology between the 2 factors, we synthesized a set of human NGF RT-PCR primers. The regions chosen for PCR primer synthesis were regions of low homology between NGF and BDNF, but of high homology between human and mouse NGF (Fig. 6) . That allowed the use of mouse salivary gland polyA+ mRNA as a positive control in the RT-PCR, and strong amplification of a fragment of the expected size (303 bp) was obtained (data not shown). No NGF mRNA was detected by RT-PCR in human platelets (Fig. 8) , which supports the specificity of BDNF cDNA ba$e pa I rs w 271;= 234r 1234567 Figure 7 . Detection of BDNF mRNA in human platelets and human astrocvtoma cell line U-87 MG using cDNA svnthesis bv M-MLV RT and random oligonucleotide prime; followed-by DNA* amplification with PCR. For the U-87 MG reactions (lanes 2, 3, 6), 0.75 pg polyA+ mRNA was used, and 2.3 pg total RNA was used for the platelet reactions ([unes 4, 5, 7) . The expected sizes of the BDNF DNA fragments amplified by the 213 and 2/4 primer pairs are 345 and 3 15 bp, respectively. Lane I, Molecular weight markers are an HaeIII digest of OX 174RF DNA. Lanes 2 and 4, BDNF 213 primer pair. Lanes 3 and 5, BDNF 2/4 primer pair. Lanes 6 and 7, Failure of BDNF primer pair l/4 to prime DNA amplification.
amplification by the 2/3 and 2/4 PCR primer pairs. A weak NGF cDNA signal was detected in the U-87 MG cell line.
DNA sequence analysis of human BDNF To confirm that a BDNF cDNA fragment had been amplified from human platelet RNA, the 345bp cDNA fragment amplified by PCR primer pair 2/3 was cloned into M 13mp8 for DNA sequence analysis using dideoxynucleotides. The sequence of the 345bp fragment amplified from both total platelet RNA ( TGT ACT TTG ACC ATT AAG AGG GGA AGA antisense clones were sequenced) and U-87 MG polyA+ mRNA (2 PCR reactions; 1 sense and 1 antisense clone from each reaction were sequenced) was determined. The identical DNA sequence was read from each clone sequenced, which indicates that the rate of random nucleotide substitutions during PCR amplification was less than 1 nucleotide in 2760 bases sequenced from 3 PCR reactions. Primer 1, which failed to amplify a BDNF cDNA in combination with primers 3 or 4, had 4 out of 24 mismatches in nucleotide sequence, and therefore probably failed to anneal adequately to the template at 53°C. The deduced amino acid sequence for human BDNF between primers 2 and 3 was completely identical to pig BDNF. Only third-base substitutions (28 of 298 bp) were observed in the region of the cDNA sequenced (Fig. 9) .
Discussion
The presence of BDNF in human platelets has been demonstrated by both bioassay and molecular cloning of a BDNF cDNA. The biological and biochemical properties of BDNF in human platelets are equivalent to those described for BDNF purified from the pig brain. Platelet BDNF supports neurite outgrowth and survival of DRG neurons that do not respond to NGF, and more importantly, like pig brain BDNF, it supports the growth of neural placode-derived nodose neurons. The apparent molecular weight of the platelet BDNF determined by SDS-PAGE is also similar to that reported for pig brain BDNF (Barde et al., 1982; Leibrock et al., 1989) . Human platelets were shown by RT-PCR to contain BDNF mRNA derived from the cytoplasm of the megakaryocyte. This allowed molecular cloning and sequencing of a fragment from the BDNF cDNA that encoded 99 of 119 amino acids of the mature factor. BDNF mRNA also is highly expressed in the human astrocytoma cell line U-87 MG and in rat C6 glioma cells (data not shown). The partial cDNA sequences determined from platelets and the astrocytoma were identical. Complete identity of the deduced amino acid sequence was found between the human and the pig for the region sequenced (aa 10-108). Sequence homology at the nucleic acid level was 9 l%, with most nucleotide sequence differences being third-base substitutions in codons.
The complete identity of human and pig BDNF over the region sequenced is unusual. The homology of human and bovine NGF is 95%, and the homology of rabbit and rat CNTF is 83%, while for the cytokines [interleukin-1 (IL-l), etc.] , homology between species can be as low as 50-60% (Oppenheim et al., 1986) .
BDNF was initially characterized in rat C6 glioma cells and in homogenates of the adult rat brain (Barde et al., 1980) . It was subsequently purified from the adult pig brain (Barde et al., 1982) . BDNF expression in the brain also rises late in development when gliogenesis is occurring (Maisonpierre et al., 1990) . Our observation, that BDNF mRNA is highly expressed in a human astrocytoma cell line as well as in rat C6 glioma cells (data not shown), suggests that BDNF synthesis may be predominantly by glia cells. Although highly expressed in the CNS, BDNF mRNA was undetectable by Northern hybridization in the peripheral tissues of the adult mice examined, which included the kidney, gut, liver, spleen, heart, and lung (Leibrock et al., 1989) . The high expression of BDNF in the brain, but the failure to detect BDNF mRNA in peripheral tissues, supports the idea that peripheral neurons that require BDNF derive trophic support through their central process. This contrasts with NGF, for which trophic support is target derived. NGF is expressed by the target tissues innervated by sympathetic and DRG sensory neurons, and trophic support is derived via the neuron's peripheral process.
In contrast to the high dependence of embryonic neurons on trophic support derived from target tissues or the CNS, adult DRG neurons are less dependent on neurotrophic factors for survival (Johnson and Yip, 1985) . Adult DRG neurons can be placed in culture and readily survive without the addition of exogenous trophic factors to the culture medium. Although the adult neurons do not require BDNF or NGF for survival, both factors enhance axonal regeneration by the cultured neurons (Lindsay, 1988) .
In addition to NGF and BDNF, another member of the NGF gene family has been identified (Hohn et al., 1990; Maisonpierre et al., 1990) . Named neurotrophin-3 (NT-3), it has neurotrophic activity for DRG, nodose, and sympathetic neurons, in contrast to BDNF, which does not support sympathetic neurons, and in contrast to NGF, which does not support nodose neurons. NT-3 is widely expressed in most adult tissues, while expression of NGF or BDNF in adult tissues is limited (Maisonpierre et al., 1990) . NT-3 expression in the brain is high during development and low in the adult, while the opposite pattern is seen for BDNF. Although exogenous BDNF will rescue nodose neurons during the period of naturally occurring cell death (Hofer and Barde, 1988) , the recent data on NT-3 and BDNF expression in the embryonic brain indicates that NT-3 may be the developmentally important factor for nodose neuron trophic support.
What might be the biological role of BDNF in human platelets? Platelets are a rich source of BDNF outside of the CNS. Extracts prepared from human platelets contain approximately 50-100 times the BDNF biological activity of porcine brain extract: 4-6 pg per ml platelet extract versus 500 pg per ml brain homogenate is required for 50% of maximal neurite outgrowth by sensory DRG neurons (Barde et al., 1982) . One possibility is that BDNF has effects on non-neural tissues. Platelets contain platelet-derived growth factor (PDGF) (Ross et al., 1986 ) and transforming growth factor-beta (TGF-P) (Assosian et al., 1983) , and these act in concert to promote proliferation of vascular smooth muscle cells after wounding of or damage to blood vessels (Bowen-Pope et al., 1985) . A role for BDNF in the response of the vessel wall to wounding should be investigated.
Platelets also contain the amyloid P-protein precursor protease nexin-II (PN-II), whose abnormal cleavage product is deposited in neuritic plaques in Alzheimer's disease (Van Nostrand et al., 1990) . PN-II is packaged in platelet a-granules. It inhibits 2 kallikrein proteases implicated in the processing of growth factor precursors, the epidermal growth factor binding protein, and the -r-subunit of NGF, as well as factor XIa, which is part of the intrinsic pathway of blood coagulation (Van Nostrand et al., 1990) . A role for PN-II in regulating the processing of the BDNF precursor in the megakaryocyte should also be considered.
In addition to being the key mediators of thrombosis and hemostasis, platelets are also immune effector cells in certain delayed-type hypersensitivity (DTH) reactions. Degranulation of both platelet and mast cells due to DTH affects vascular permeability. Mast cell degranulation is stimulated by binding of IgE to cell-surface Fc receptors, by certain components of complement, and by NGF (Bruni et al., 1982) . Although mast cells normally may not be exposed to sufficient NGF to trigger degranulation in vim, a role for BDNF released from platelets in triggering mast cell degranulation should be evaluated.
The relatively large amounts of BDNF in human platelets might also be an important source of neurotrophic support after damage to peripheral nerves and another example of the interplay between the immune system and neural cells at the site of nerve lesion. For example, transection of the sciatic nerve enhances local NGF synthesis up to 15-fold by non-neuronal cells, which include Schwann cells, epithelial cells, smooth muscle cells, and fibroblasts Heumann et al., 1987) . Both IL-1 and PDGF can trigger local synthesis of NGF by non-neuronal cells (Lindholm et al., 1987) . After traumatic disruption of the blood-nerve barrier and extravasation ofblood into the endoneurium, infiltrating macrophages will be a cellular source of IL-1, while PDGF will be released from platelets. The binding of platelets to 3 components of the extracellular matrix (collagen, laminin, and fibronectin) exposed by injury is an initial event in their activation. Binding to collagen induces platelet aggregation and consequent degranulation, while binding to laminin or fibronectin does not induce activation (Ill et al., 1984) . Thus, the binding of platelets to matrix components may deliver BDNF to matrix substrates that can support neurite outgrowth by regeneraating sensory neurons.
The mechanism of the release of BDNF from platelets and the possible synthesis of BDNF by non-neuronal cells at the site of peripheral nerve trauma have yet to be examined. Local NGF synthesis by non-neuronal cells at the site of nerve injury and the release of BDNF by platelets at the site of the lesion may both provide trophic support for regenerating sensory neurons. Thus, in addition to PDGF and TGF-P, which promote vascular repair, BDNF in platelets may be another important factor for promoting tissue regeneration.
